Drug Approval | July 26, 2023
Eugia Pharma receives USFDA approval for Plerixafor Injection
The approved product has an estimated market size of around US$ 210 million for the twelve months ending May 2023
The approved product has an estimated market size of around US$ 210 million for the twelve months ending May 2023
Teva will leverage Honeywell’s ‘Energy as a Service’ (EaaS) model
Through the use of robotic assisted orthopaedic surgeries, the success rate is close to 98%
Acquisition of biologics manufacturing facility in Bangalore to complete by the end of the third quarter in FY 24
CARA is a data and content management platform that helps companies in regulated industries such as finance, energy, and manufacturing transform their complex business processes
Erdafitinib is indicated for the treatment of adult patients with locally advanced or metastatic urothelial carcinoma
The approval allows treatment of heart failure patients irrespective of the ejection fraction based on new trial DELIVER conducted by AstraZeneca
AIIMS established in Bilaspur, Nagpur, Rae Bareli and Gorakhpur
Health-tech startups have the potential to revolutionize the healthcare sector by supporting innovations
Apollo Transplant program is the first program in India to cross the landmark of 18500 kidney transplants, 4300 liver transplants and 500 pediatric liver transplants
Subscribe To Our Newsletter & Stay Updated
